Silver Lake Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Silver Lake Advisory’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$378K	Buy	754 +1	+0.1%	+$480	0.14%	89
2026 Q1	$370K	Hold	753	–	–	0.15%	87
2025 Q4	$436K	Hold	753	–	–	0.17%	80
2025 Q3	$365K	Buy	753 +1	+0.1%	+$465	0.15%	82
2025 Q2	$305K	Hold	752	–	–	0.13%	89
2025 Q1	$374K	Hold	752	–	–	0.16%	83
2024 Q4	$391K	Buy	752 +1	+0.1%	+$550	0.17%	80
2024 Q3	$465K	Hold	751	–	–	0.19%	77
2024 Q2	$415K	Hold	751	–	–	0.19%	74
2024 Q1	$436K	Buy	+751	New	+$421K	0.19%	74
2023 Q3	–	Sell	-760	Closed	-$396K	–	88
2023 Q2	$396K	Hold	760	–	–	0.21%	73
2023 Q1	$438K	Buy	+760	New	+$428K	0.24%	63
2022 Q4	–	Sell	-759	Closed	-$385K	–	88
2022 Q3	$385K	Hold	759	–	–	0.23%	69
2022 Q2	$412K	Buy	759 +10	+1%	+$5.5K	0.22%	68
2022 Q1	$442K	Hold	749	–	–	0.21%	77
2021 Q4	$499K	Buy	749 +1	+0.1%	+$624	0.23%	76
2021 Q3	$428K	Buy	748 +30	+4%	+$16.5K	0.21%	81
2021 Q2	$386K	Hold	718	–	–	0.18%	85
2021 Q1	$328K	Hold	718	–	–	0.17%	81
2020 Q4	$334K	Hold	718	–	–	0.18%	78
2020 Q3	$317K	Buy	718 +1	+0.1%	+$413	0.2%	73
2020 Q2	$260K	Hold	717	–	–	0.17%	76
2020 Q1	$203K	Hold	717	–	–	0.15%	81
2019 Q4	$233K	Hold	717	–	–	0.14%	76
2019 Q3	$209K	Buy	717 +1	+0.1%	+$286	0.14%	79
2019 Q2	$210K	Buy	+716	New	+$197K	0.14%	80

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Silver Lake Advisory's TMO Position: Q2 2026 in Review

Silver Lake Advisory increased its Thermo Fisher Scientific (TMO) stake by 0.13% in Q2 2026, buying an estimated $480 and bringing the position to 754 shares worth $378K. The position accounts for 0.14% of the portfolio, ranked #89.

Silver Lake Advisory first reported a position in TMO in Q2 2019 and has held it in 26 quarters since. The position peaked at $499K in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Silver Lake Advisory held 754 shares of Thermo Fisher Scientific worth $378K as of Q2 2026.
Silver Lake Advisory bought 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
Thermo Fisher Scientific made up 0.14% of Silver Lake Advisory's portfolio in Q2 2026, its #89 holding.
Silver Lake Advisory first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 26 quarters since.
Silver Lake Advisory's Thermo Fisher Scientific position peaked at $499K in Q4 2021.
2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Silver Lake Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.